March 2021 Awareness Night 25 YEARS IN PROSTATE CANCER CARE: Where we were and where we are headed Dr. Gerard Morton, MD, FRCPC Sunnybrook Health Science Centre CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation time is 1:19:39 <
July 2020 Awareness Night Brachytherapy: The evolving roles of Brachytherapy for prostate cancer: teaching an old dog even newer tricks! Dr. Alejandro Berlin, MD, MScClinician-Scientist Radiation Medicine Program, Princess Margaret Cancer Centre Asst. Professor, Dept. of Radiation, U. of Toronto This Awareness Night was held on the Zoom platform. The session will include a Q and A component. CLICK ON THE ARROW TO START THE VIDEOThe Complete Presentation time is 1:22:23 <
March 2018 Awareness Night How clinical trials have changed prostate cancer care Dr. Andrew Loblaw BSc MD MSc FRCPC CIP Clinician Scientist , Ontario Association of Radiation OncologyStaff Radiation Oncologist & Clinician Scientist, Sunnybrook Health Sciences Centre Scientist, Sunnybrook Research Institute Fellow, American Society of Clinical Oncology (ASCO) Co-Chair, GU group for Cancer Care Ontario’s Program in Evidence-Based Care Previous Co-Chair, ASCO’s Genitourinary Advisory Group Professor, Department of Radiation Oncology at University of Toronto Professor,The Institute of Health Policy, Management and Evaluation (IHPME) CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 66:27 minutes
September 2017 Awareness Night Brachytherapy for Prostate Cancer and Breast Cancer Dr. Juanita Crook, MD, FRCPC Professor of Radiation Oncology, University of British Columbia Radiation Oncologist, Center for the Southern Interior in Kelowna BC CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 47:27 minutes
A study by researchers at the UCLA Jonsson Comprehensive Cancer Center provides convincing evidence that radiation-based treatments and surgery are equally effective treatments for aggressive prostate cancer. It also suggests that a particular form of radiation therapy, consisting of external radiation followed by brachytherapy (a type of radiation treatment in which a radioactive source is placed into the tumor directly) provides the best chance of preventing metastatic disease. Read the article here.
Some experts see Cesium-131 as an optimal version of brachytherapy because it is both fast-acting and has a shorter delivery time than other brachytherapies — about 30 days. A key advantage is shorter recuperation periods, meaning patients can recover their urinary, bowel, and sexual functions quicker than with other brachytherapy solutions. Read the article here.